Back to Type 2 Diabetes
NCT02252224
NCT02252224
Who may be able to join
Who might be able to join this trial:
- You must be 18 years of age or older
- You must have type 2 diabetes and be eligible to take the medication Forxiga based on the approved guidelines in your country
- You must have signed and dated a consent form showing you have been fully informed about the study (a legal representative may sign on your behalf if needed)
Who may not be able to join:
- You may not be eligible if you are already taking Forxiga in a way that is not in line with the officially approved guidelines in Korea
- You may not be eligible if you have any medical reasons that prevent you from safely taking Forxiga, as outlined in the Korean medication guidelines (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
AstraZeneca
Registry
clinicaltrials_gov
Start date
23 September 2014
Est. completion
30 November 2016
Where this trial is recruiting
🇰🇷 South Korea
Primary endpoints
The number and incidence rate of adverse events and serious adverse event including unexpected adverse drug reactions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.